LOUIS G. LANGE

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Louise Kooij by Power of Attorney from Louis G. Lange
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LOUIS G. LANGE:

Company Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 10,360 $363,586 $35.10 07 Jan 2026 Direct
NewAmsterdam Pharma Co N.V. Director Option (right to buy) 15,300 07 Jan 2026 Direct
NewAmsterdam Pharma Co N.V. Director Restricted Stock Unit 0 01 Jun 2025 Direct

Insider Reports Filed by LOUIS G. LANGE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NAMS NewAmsterdam Pharma Co N.V. 07 Jan 2026 2 $0 4 Director 09 Jan 2026, 19:33
NAMS NewAmsterdam Pharma Co N.V. 01 Jun 2025 2 $0 4 Director 03 Jun 2025, 16:59
NAMS NewAmsterdam Pharma Co N.V. 01 May 2025 2 $0 4 Director 02 May 2025, 16:55
NAMS NewAmsterdam Pharma Co N.V. 14 Apr 2025 2 $0 4 Director 21 Apr 2025, 17:41
NAMS NewAmsterdam Pharma Co N.V. 26 Mar 2025 3 $0 4 Director 28 Mar 2025, 17:24
NAMS NewAmsterdam Pharma Co N.V. 06 Jan 2025 2 $0 4 Director 08 Jan 2025, 17:57
NAMS NewAmsterdam Pharma Co N.V. 13 Feb 2024 1 +$95,000 4 Director 21 Feb 2024, 17:00
NAMS NewAmsterdam Pharma Co N.V. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 17:17
NAMS NewAmsterdam Pharma Co N.V. 29 Dec 2023 0 $0 3/A Director 25 Jan 2024, 17:00
NAMS NewAmsterdam Pharma Co N.V. 29 Dec 2023 0 $0 3 Director 29 Dec 2023, 16:30
/report/000089924322032792-lange-louis-g-2022-09-16 Epiphany Technology Acquisition Corp. 16 Sep 2022 0 $0 3 Director 04 Oct 2022, 19:55
/report/000156761921021519-lange-louis-g-2021-12-02 BioPlus Acquisition Corp. 02 Dec 2021 0 $0 3 Director 02 Dec 2021, 18:45